# Regulatory Mechanisms of Sterol Regulatory Element-Binding Protein-Dependent Human ELOVL6 Expression in Response to Free Fatty Acids

**Authors:** Michiko Tajiri-Mori, Riko Kitazawa, Kiyoshi Mori, Ryuma Haraguchi, Sohei Kitazawa

PMC · DOI: 10.7759/cureus.104449 · Cureus · 2026-02-28

## TL;DR

This study explores how free fatty acids regulate the ELOVL6 gene through SREBP proteins, revealing a transient and tightly controlled mechanism important for lipid balance.

## Contribution

The study identifies and characterizes two functional SREs in the human ELOVL6 promoter that mediate SREBP-dependent fatty acid-responsive transcription.

## Key findings

- Palmitic acid induces a transient upregulation of ELOVL6 mRNA in human hepatoma cells.
- Both SRE1 and SRE2 are essential for fatty acid-responsive transcription of ELOVL6.
- Nuclear SREBP accumulation peaks early after PA stimulation and declines, correlating with transient ELOVL6 induction.

## Abstract

ELOVL6 is a key microsomal enzyme that catalyzes the elongation of C16 saturated and monounsaturated fatty acids into C18 species and plays a pivotal role in lipid homeostasis. Although ELOVL6 is recognized as a downstream target of sterol regulatory element-binding proteins (SREBPs), the promoter architecture and the functional contribution of individual sterol regulatory elements (SREs) within the human ELOVL6 gene remain poorly characterized. In this study, we investigated the transcriptional regulation of human ELOVL6 in response to free fatty acids, focusing on SREBP-mediated mechanisms. A 1.6 kb genomic region encompassing the human ELOVL6 promoter and first intron was cloned, and two putative SREs, designated SRE1 and SRE2, were identified. Using human hepatoma Huh7 cells, we found that palmitic acid (PA), but not oleic acid (OA), induced a transient upregulation of ELOVL6 mRNA expression at 24 h, which diminished by 48 h. Electrophoretic mobility shift assays and chromatin immunoprecipitation analyses demonstrated specific binding of SREBP to both SRE1 and SRE2, with enhanced recruitment following PA stimulation. Luciferase reporter assays revealed that site-directed mutagenesis of either SRE significantly reduced basal promoter activity, while simultaneous disruption of both elements resulted in profound suppression, indicating that both elements are essential for fatty acid-responsive transcription. Consistent with these findings, PA stimulation caused a rapid but transient accumulation of nuclear SREBP, peaking at 4 h and declining thereafter, suggesting that the short nuclear half-life of active SREBP contributes to the transient induction of ELOVL6. Collectively, these results delineate the cis-regulatory framework of the human ELOVL6 gene and demonstrate that SRE1 and SRE2 cooperatively mediate SREBP-dependent, fatty acid-responsive transcription. This tightly regulated and transient activation of ELOVL6 may represent an adaptive mechanism to acute lipid-derived stress, the dysregulation of which could contribute to metabolic disorders and cancer-associated lipid remodeling.

## Linked entities

- **Genes:** ELOVL6 (ELOVL fatty acid elongase 6) [NCBI Gene 79071], sre-1 (Serpentine receptor class epsilon-1) [NCBI Gene 191827], sre-2 (Serpentine receptor class epsilon-2) [NCBI Gene 174302]
- **Proteins:** SREBP (Sterol regulatory element binding protein), ELOVL6 (ELOVL fatty acid elongase 6)
- **Chemicals:** palmitic acid (PubChem CID 985), oleic acid (PubChem CID 445639)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** ELOVL5 (ELOVL fatty acid elongase 5) [NCBI Gene 60481] {aka HELO1, SCA38, dJ483K16.1}, Elovl6 (ELOVL fatty acid elongase 6) [NCBI Gene 170439] {aka FAE, LCE}, CNBP (CCHC-type zinc finger nucleic acid binding protein) [NCBI Gene 7555] {aka CNBP1, DM2, PROMM, RNF163, ZCCHC22, ZNF9}, SREBF1 (sterol regulatory element binding transcription factor 1) [NCBI Gene 6720] {aka HMD, IFAP2, SREBP1, bHLHd1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, ELOVL6 (ELOVL fatty acid elongase 6) [NCBI Gene 79071] {aka FACE, FAE, LCE, hELO2}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, LMNB1 (lamin B1) [NCBI Gene 4001] {aka ADLD, LMN, LMN2, LMNB, MCPH26}
- **Diseases:** hepatocellular carcinoma (MESH:D006528), metabolic disease (MESH:D008659), hepatic steatosis (MESH:D005234), obesity (MESH:D009765), breast cancer (MESH:D001943), insulin resistance (MESH:D007333), NAFLD (MESH:D065626), Crohn's disease (MESH:D003424), cancer (MESH:D009369), hyperinsulinemia (MESH:D006946), colorectal cancer (MESH:D015179), associated steatotic liver disease (MESH:D008107), inflammation (MESH:D007249)
- **Chemicals:** cholesterol (MESH:D002784), glucose (MESH:D005947), formaldehyde (MESH:D005557), glycine (MESH:D005998), NaOH (MESH:D012972), DTT (MESH:D004229), oligonucleotides (MESH:D009841), OA (MESH:D019301), biotin (MESH:D001710), KCl (MESH:D011189), C18 (MESH:C109760), lipid (MESH:D008055), FFA (MESH:D005230), PA (MESH:D019308), sterol (MESH:D013261), poly(dI-dC) (MESH:C031156), borate (MESH:D001881), CO2 (MESH:D002245), CBB (MESH:C004692), polyacrylamide (MESH:C016679), Fatty acid (MESH:D005227), monounsaturated fatty acids (MESH:D005229), EDTA (MESH:D004492), glycerol (MESH:D005990), nylon (MESH:D009757), MgCl2 (MESH:D015636), C16 saturated and monounsaturated fatty acids (-), fat (MESH:D005223)
- **Species:** Anas platyrhynchos (duck, species) [taxon 8839], Sus scrofa (pig, species) [taxon 9823], Bos taurus (bovine, species) [taxon 9913], Larimichthys crocea (croceine croaker, species) [taxon 215358], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Scylla paramamosain (green mud crab, species) [taxon 85552]
- **Mutations:** ATCCGCCCAC to ATCCTTTTAC, TCGCACGAG to CCACATCGC
- **Cell lines:** Huh7 — Homo sapiens (Human), Adult hepatocellular carcinoma, Cancer cell line (CVCL_0336)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949678/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12949678/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949678/full.md

---
Source: https://tomesphere.com/paper/PMC12949678